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When Metchnikoff defined the process of phagocytosis in  1884 (1,  2),  he 
conceded to  serum  the minor  role  of an dement that merely modified the 
phagocyte. However,  in  1903 Wright  and Douglas  clearly established  that 
phagocytosis of  pathogenic  bacteria  could  not  occur  without  serum;  that 
this effect was  achieved by modification of the microorganism rather  than 
the phagocyte; and that immunity developed in the serum, not the leukocyte 
(3, 4). Whether this serum effect was accomplished by specific antibody alone 
or by antibody acting in  conjunction with  a  nonspecific, heat-labile serum 
activity, namely complement, was not dear until the experiments of Ward 
and Enders in 1933. They demonstrated that ingestion of pneumococci could 
occur slowly in the presence of heated immune serum; however, the addition 
of small amounts of fresh, nonimmune serum markedly enhanced the  rote 
of ingestion (5). 
The heat-labile factor or factors necessary for optimal phagocytosis of bac- 
teria have not been precisely identified. On the basis of their own and other 
available experimental data, Boyden et al. found it impossible to define the 
role of thermolabile factors as opsonins and pointed out the need for a means 
of accurately measuring phagocytosis of bacteria (6).  The present report de- 
scribes a  spectrophotometric method of measuring bacterial phagocytosis and 
its application to demonstrate that the first four components of human com- 
plement and two serum cofactors are necessary for the optimal phagocytosis of 
pneumococci by human leukocytes. 
Materials  and Metkods 
Pntumo¢occi.--Diplocotcus tmettmoniae, type II, was obtained from the Department of 
Microbiology, Harvard Medical School, through the kindness of Miss Marjorie Jewell. It 
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was maintained in virulent form by passage through white laboratory mice which were frozen 
at  -20°C upon death.  Fresh cultures were prepared  by thawing the mice and inoculating 
heart blood into Todd-Hewitt broth and onto blood agar plates. 
Preparation of Immune Antibody and Sensitization of Pneumocoeci.--Antiserum  to type II 
lbt/eumococci  was raised  in  rabbits  by  repeated  injections of formalinized,  heat-killed  or- 
ganisms.  Gamma G globulin (q/G)was separated from the antiserum  by single-step elution 
from diethylaminoethyl  (DEAE)  cellulose with 0.007  M sodium phosphate  buffer,  pH 6.3. 
The eluate was dialyzed against 0.15 M NaC1 before use. 
Overnight cultures of pneumococci were formalinized (final  volume 1%), heated at 65°C 
for 30 rain, centrifuged at 8000 g for 15 rain,  washed three times with 0.15 ~s saline, and re 
suspended in a 17 mm diameter tube to an optical density (OD) of 0.500 at 620 m/z in a Cole- 
man Junior spectrophotometer.  Two volumes of the pneumococcal suspension were mixed 
with one volume of antibody and incubated at 37°C for 30 rain.  The sensitized bacteria were 
centrifuged at 8000 g for 15 min, washed twice, and resuspended  in sucrose-saline veronal 
buffer,/t 0.065,  pH  7.35  (7)  (hereafter termed  verona1  buffer),  and  the OD was adjusted 
to 0.150 at 620 m/~ in a  Coleman Junior spectrophotometer. This corresponded to a  concen- 
tration of approximately 9 X  10  s sensitized bacteria/ml. 
Preparation or Leukocyte Suspensions.--Human  venous blood  was collected in heparinized 
plastic syringes and one-fourth volume of 6% dextran in  saline was added. The syringe tip 
was fitted with a curved 18 gauge needle, the syringe was rested on its plunger, and the blood 
was allowed to sediment at room temperature for 60-90 rain. With the syringe still upright, 
leukocyte-rich plasma was separated  by pressure on the plunger and centrifuged in plastic 
conical tubes at 200 g for 15 rain. The cell pellet was resuspended and agitated in approxi- 
mately 50 volumes of 0.87% NI-I~CI to lyse red cells, centrifuged for 4 rain, and washed twice 
in Krebs-Henseleit bicarbonate buffer (8), pH 7.35, containing 200 rag/100 ml glucose.  The 
final cell pellet was suspended in 10-20 volumes of this buffer, and the volume of this suspen- 
sion which contained 2.5 X  106 phagocytic cells (monocytes, juvenile and adult polymorpho- 
nutlears)  was determined. Ordinarily, this number of phagocytes was contained in approxi- 
mately 0.1 ml. 
Normal and Complement-Deficient Sera.--Normal serum was separated from freshly clotted 
blood, frozen in small aliquots at --65°C, and thawed as required. Complement activity was 
destroyed by heating to 56°C for 30 rain, or by treatment with 0.01 M NaaI-I EDTA  l, 0.025 M 
hydrazine anhydride, or 1 t,g/mi serum of Naja naja venom (Ross Allen's Reptile Institute, 
Inc., Silver Springs, Fla.). Sera specifically deficient in C2 were obtained  from two healthy 
males homozygons for an hereditary deficiency of this component and from relatives heterozy- 
gous for the deficiency (9, 10). Sera specifically deficient in C3 were obtained from two chil- 
dren with progressive glomerulonephritis (11),  an adult male with acute glomerulonephritis 
(12),  and three individuals who are heterozygous  for hereditary C3 deficiency (13).  Serum 
from DBA strain mice with an hereditary deficiency of C5 (14) was kindly donated by Dr. 
Henry Winn. Serum from rabbits deficient in C6 (15, 16) was generously given by Dr. Shaun 
Ruddy and Dr. Carlos Biro. 
Purification  o/Human  Complement  Components.--The  C1  maeromolecule was  purified 
from human serum by the method  of Nelson (17). C4 was isolated by a modification of the 
method of Miiller-Eherhard and  Biro (18),  C2 by the method of Lepow et al. (19), and C3 
by the method of Nllsson and Mtiller-Eberhard  (20).  C2 was  iodinated  by the method of 
Policy and Mt:iler-Eberhard (21). C3 and iodinated C2 were dialyzed against veronal buffer 
at 4°C for 4 he before use. 
Pcptide SoluHons.--Glycyl-L-tyrosine,  glycyl-L-leucyl-L-tyrosine,  giycyl-L-leucine,  giycyl-L- 
serine,  and  giycyl-r.-valine were  obtained  from  Mann  Research  Laboratories,  New York, 
, Trisodium hydrogen ethylene diamine tetraacetate. ~OHNSTON~ KLEMPERERI  ALPER~ AND ROSEN  1277 
N.Y.  Peptides were dissolved in veronal buffer to a  concentration of 0.04-0.2  •,  adjusted 
to pH  7.35  with 2  N  NaOH,  and stored at  --20oC. These stock solutions were diluted in 
veronal buffer immediately before each experiment. 
Preparation of Dialysate.--Human serum was dialyzed against an equal volume of physi- 
ological saline at 0°C for 4 hr (22). The dialysate was stored at --65°C. 
Quantitation of P~tagocytosis 
Spectrophatometric Measurement of Reduced Nitro  Blue Tetrazolium (NBT).--The method 
of Baehner and Nathan (23)  was modified for the study of bacterial phagocytosis. A 0.2% 
solution of NBT, Grade III (Sigma Chemical Co., St. Louis, Mo.) in physiological saline was 
faltered through Whatman No. 1 paper, and stored at 4°C in an opaque bottle. The standard 
test system consisted of 0.4 ml NBT solution, 0.2 ml sensitized pneumococci, and 0.08 ml 
fresh human serum in 12 ml siliconized conical centrifuge tubes to which 2.5 X  10  e phage: 
cytes were added after a  10 rain preincubation at 37°C.  Reaction volumes were equalized 
when necessary with veronal buffer. After a  20 rain incubation at 37°C in a  reciprocating 
water bath, the reaction was terminated by the addition of 0.1 ~  HC1 in physiological saline. 
The tubes were then centrifuged at 1400 g for 15 rain at 4°C, the supematant was discarded, 
and the purple cell button was extracted with 2 ml pyridine, reagent grade (Fisher Scientific 
Co., Fair Lawn, N. J.)  in a  boiling water bath for 10 rain. The tubes were centrifuged at 
500 g for 5 rain and the extraction repeated with 2 ml pyridine. The extracts were combined 
and their optical density measured in a  Zeiss spectrophotometer at 515 m#. All assays were 
run in duplicate. 
Microscopic Enumeration  of Ingested Bacteria.--2.5  million phagocytes in 0.1 ml volume 
were added to 0.2 ml sensitized pneumococoi suspension, 0.08 fresh human serum, and 0.4 
ml physiological saline in 10 X  71 mm siliconized glass tubes. These were incubated on a 
revolving wheel at 37°C for 20 rain, then coverslip smears of the mixture were stained with 
Wright's stain and coded. The number of cocci in 100 consecutive polymorpbounclear and 
monocytic phagocytes was counted, and the average number of cocci per phagocyte  (the 
phagocytic index) was determined. In this system 98-100% of phagocytes ingested at least 
one bacterium in the presence of normal serum. 
Uptake of l~I-Pneumococci by a Phagocytic Monolayer.--The method of Micheli and co- 
workers (24) was used to study the uptake of labeled pneumococci by phagocytes attached 
to the surface of a Petri dish. Pneumococci were labeled with x~I (25), sensitized with specific 
rabbit 7G and suspended as described above. The reaction mixture was that of the N'BT 
assay except that 0.2 ml of the labeled bacteria were suspended in veronal buffer to 0.52 ml, 
making the reaction volume 1 ml. 
Bactericidal Capacity.--The method used was based on that of MaalOe as modified by 
Quie et al. (26). Immediately before use, a 5 hr broth culture of pneumococci was suspended 
in a  17 mm diameter tube to an OD of 0.100 at 620 m/~ in a Coleman Junior spectrophotom- 
eter and diluted  l: 10 in phosphate buffered saline, pH 7.4,  cont~,inlng 10% T~xtd-Hewitt 
broth and 10% serum albumin. To 12 X  75 mm sterile capped plastic tubes (Falcon Plastics 
Co., Los Angeles, Calif.) were added 0.05 ml of type-specific rabbit antiserum heated to 56°C 
for 30 rain, 0.08 ml of fresh serum or buffer, 0.07 ml serum albumin, 2.5 X  10  ¢ phagocytes 
suspended in 0.5 ml sterile Krebs-Henseleit buffer, and finally, 0.3 ml of the pneumococcal 
suspension. This was calculated to give 1 or 2 bacteria per phagocyte in a total reaction volume 
of 1 ml. The contents of the tube were immediately mixed, and 0.01 ml of the mixture was 
transferred by calibrated platinum loop or micropipette to a  100 X  17 nun capped plastic 
tube (Falcon) containing 6 ml of sterile water. After vigorous shaking of the tube for 30 sec, 
a  0.5 ml aliquot was removed to make a  pour plate with 12 ml of Todd-Hewitt agar. The 
original reaction tube was then placed on a revolving wheel at 37"C, and additional samples 
were obtained for colony counting at intervals up to  120 rain. Colonies were counted the 
following day and expressed as number of surviving bacteria per ml of incubation mixture. 1278  ENHANCRM'RNT  OF BACTERIAL  PHAGOCYTOSIS  BY SERUM 
RESULTS 
Spectrophotomelric  Quantitation  of Pl,  agocytosis.---Quantitation  of phagocy- 
tosis was achieved by the spectrophotometric  measurement of nitro blue tetra- 
zollum  (NBT)  dye reduced  to a  blue  color in proportion to the number of 
pneumococci ingested.  As shown in Fig. 1, the optical density of the dye re- 
duced was proportional to the number of bacteria in the system until the ratio 
of bacteria to phagocytes reached  approximately 75:1.  Increasing this ratio 
with additional bacteria did not increase the amount of NBT reduced. 
When the bacteria:phagocyte ratio of approximately 75:1  was maintained 
and the volume of fresh human serum in the reaction mixture was varied, an 
arithmetic plot of the dye reduction was sigmoidal  (Fig. 2). Optimal dye re- 
duction was achieved with approximately 0.08 ml serum. 
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FIO. 1.  The optical density of NBT dye reduced during the phagocytosis of pneumococci 
plotted as a function of the number of bacteria available for ingestion. Type-specific antibody 
and 0.08 ml fresh serum were present in the system. 
The effect of the duration of incubation of the reaction mixture on the dye 
reduction and on the number of ingested bacteria per phagocyte (phagocytic in- 
dex) is compared in Fig. 3. Both reactions proceeded rapidly for approximately 
15 rain, and the plot of the dye reduction was parallel to but slightly slower than 
that of the phagocytic index. After 15 rain, the rate of both reactions decreased, 
and by 25  min no further increase  in phagocytosis  was  detected by either 
method. The effect of the length of incubation on the uptake of ~6I-pneumo- 
cocci by fixed phagocytes was also studied. The increase in phagocytosis with 
time noted in this system was the same as that described  for NBT reduction 
and phagocytic index.  Uptake of labeled  bacteria was rapid for 15 rain and 
complete by 25 rain. When viable pneumococci were incubated with antibody, 
fresh serum, and phagocytes, and the rate of bacterial killing was determined, 
it was found that ingestion, measured by the phagocytic index, and dye reduc- 
tion were complete before most of the bacterial killing occurred  (Fig. 3). JOHNSTOlq~ KLEMPERER~  AI.PER~ AND  ROSEN  1279 
Quantitation of Pkagocytosis in the Presence of Complement-Deficient Sera.-- 
Various sera specifically deficient in one of the complement components were 
tested for their ability to enhance bacterial phagocytosis in order to ascertain 
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F]o. 2.  The optical density of 1VBT dye reduced during the phagocytosis of pneumococci 
plotted as a ftmction of the volume of fresh normal serum in the system. The bacteria were 
spreviouly prepared with type-specific antibody. 
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FIG. 3.  The optical density of reduced NBT dye, the number of pneumococci per phago- 
cyte (phagocytic index), and the number of viable bacteria per ml of reaction mixture plotted 
as a function of the length of time during which plmgocytosis was allowed to occur. 
which  components are  necessary for this  process. When  normal  serum was 
replaced in the assay system by an equal volume (0.08 ml) of human serum 
deficient in C2 or C3, no enhancement of phagocytosis was  observed (Table 
I). The results obtained with varying amounts of sera deficient in  C2  or  C3 1280  ENHANCEMENT  OF  BACTERIAL  PHAGOCYTOSIS  BY  SERUM 
are compared in Fig. 4. The C2-deficient serum which contained less than 5 % 
of the normal C2 concentration (10) was more effective in promoting phago- 
cytosis  than  equal volumes  of  C3-deficient serum which contained approxi- 
mately 8 % of the normal C3  concentration. When serum was heated at 56°C 
for 30 min, or treated with hydrazine, EDTA, or cobra venom, it no longer 
enhanced phagocytosis (Table I). 
When serum from mice with an inherited deficiency of C5  or  serum  from 
rabbits  genetically deficient  in C6  were  compared  to  the  normal serum  of 
their species, there were no significant differences in their ability to promote 
phagocytosis (Figs. 5 and 6). 
TABLE I 
Enhancement of Phagocytosis of A ntibody-Sensi~ized Pneumococci by Complement-Deficient  Sera* 
C-Deficient serum 
NO serum 
Heated 
Hydrazine-treated 
EDTA-treated 
Cobra venom-treated 
C2 deficiency: 
Hereditary 
Homozygous  1 
2 
Heterozygous  1 
2 
Serum C2 
coneen- 
tmtlon 
m~l~m2$ 
<0.05 
<0.05 
0.3 
0.3 
OD 
0.042 
0.055 
0.045 
0.027 
0.017 
0.071 
0.068 
0.271 
0.317 
C-Deficient  serum 
C3 Deficiency: 
Hereditary  1 
2 
3 
Acquired  1 
2 
3 
Serum ca 
concert-  OD 
tration 
ragl  l  O0 ral  ~ 
81  0.183 
62  0. 128 
54  0.140 
14  0.074 
12  0.055 
<5  0.030 
* Measured by the optical density (OD) at 515 m/.~ of NBT dye reduced during phago- 
cytosis. Serum volume was 0.08 ml. The mean OD for 72 determinations of normal serum was 
0.386, and the range was 0.304 to 0.520. 
Normal value for C2, 1 4- 0.2 mg/100 ml, for C3, 150 4- 50 rag/100 ml. 
Enhancement  of Phagocytosis  by Purified Complement  Components.--It  was 
apparent from  these  results  that  C1,  C4,  C2  and  C3  were  needed  to  en- 
hance  bacterial  phagocytosis,  whereas  C5  and  C6  and,  presumably,  the 
later-reacting components had no demonstrable effect on this process. 
Pneumococci were prepared  for  phagocytosis by the  addition  of purified  complement 
components. Equal volumes of  the  pneumococci-antibody suspensions (0.3 ml)  and  C1 
in veronal buffer were incubated together at 30°C for 30 rain, centrifuged at 8000 g at 0°C 
for 15 rain, and washed once in cold veronal buffer. The washed complex was resuspended 
in 0.3 ml of  C4 in veronal buffer, incubated at 37°C for 30 rain, and centrifuged again at 
8000 g for  15 min. The pneumococci-antibody-Ci,4  complex was  resuspended  in 0.2  mt 
oxidized C2  and incubated at 30°C for 8 min; 0.3 mg C3 was added  and incubation was 
continued at 30°C for 10 rain, after which NBT and phagocytes were added. JOHNSTON~ KLEMPERER~ ALPER~ AND ROSEN  1281 
When  the  pneumococci  were  prepared  with  C1  alone;  C1  and  C3;  C1, 
C4, and  C2; or  C1,  C4,  and  C3  prior  to  the  addition  of NBT  and  phago- 
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Fro. 4. A comparison of the optical density of NBT dye reduced during the phagocytosis 
of sensitized pneumococci in the presence of normal,  C2-deficient, and  C3-deficicnt fresh 
human serum, plotted as a function of the volume of serum in the reaction mixture. 
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FIG. 5. A comparison of the optical density of NBT dye reduced during the phagocytosis 
of pneumococci in the presence of normal or C5-deflcient mouse serum, plotted  as a function 
of the volume of serum in the reaction mixture. 
cytes,  no  increase  in  phagocytosis was  observed  (Table  II).  The  sequential 
addition  of C1,  C4,  C2,  and  C3  did  result  in  significant  enhancement  of 
phagocytosis  (Table  II); however,  repeated  experiments  with  these  purified 
complement components in concentrations in excess of those in normal serum 1282  ERrHAhTCEMENT  O1~  BACTERIAL  PHAGOCYTOSIS  BY  SERUM 
failed to achieve an O1:) that was more than 50% to 60% of the average OD 
of 72  determinations with fresh serum (0.386,  range 0.304-0.520).  Therefore, 
it seemed possible that other factors which  are not complement components 
might be required for optimal sensitization. 
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Fxo. 6. A comparison of the optical density of NBT dye reduced during the phagocytosis 
of pneumococci  in the presence of normal or C6-deficient rabbit serum, plotted as a function 
of the volume,'of  serum in the reaction mixture. 
TABLE II 
Enhancement of Phagocytosis by the Addition of Purified Complement Components 
to Sensiffzed Pneumococci 
Components  added 
i 
~Tone 
c1 
c1,3 
C1,4,2 
C1,4,3 
CI,4,2,3 
OD* 
0,058 
0.054 
0.074 
0.058 
0.082 
0.217 
* Optical density at 515 m/t of N-BT  dye reduced during phagocytosis. 
Enhancement  of  Phagocytosis  of  Pneumococci  Prepared  with Antibody  and 
C1,4,2,3  by  a  Dialysate of Human  Serura.--It  was  observed  in  1957  that 
peptides containing  an aromatic amino acid inhibited  immune hemolysis by 
guinea pig complement (27,  28).  In  1965 Basch  showed  that  this inhibition 
occurred  between  the  erythrocyte-antibody  (EA)  CI,4,~  step  and  the 
intermediate EA C1 ,~ 7, and that these peptides inhibited immune adherence 
in a  rank order similar to that for their inhibition of immune hemolysis (29). 
Thus, the evidence suggested that the activity of cell bound  C3 was inhibited JOHNSTON, KLEM]?EEER, ALPER, AND ROSEN  1283 
by the peptides. Cooper and Becker confirmed  this in 1967 when they showed 
that  complexed  guinea  pig  C3  hydrolyzed  peptides  containing  aromatic 
amino  acids  (30).  Cooper also demonstrated  that  this peptidase  activity of 
C3  was  enhanced  by a  dialysate of whole guinea pig serum (22).  If human 
C3 has similar peptidase activity and if this activity is essential for phagocyto- 
sis, aromatic ~rnluo acid-containing peptides might inhibit phagocytosis. 
When  glycyl-L-tyrosine in  concentrations  greater  than  5  X  10  -~  M was 
present in the phagocytic system, inhibition of phagocytosis occurred (Fig. 7). 
Inhibition was also obtained with 4 X  10  -8 zt and 9 X  10  -~ M glycyl-L-leucyl-L- 
tyrosine, but not with 8 X  10  -8 rr glycyl-L-leucine, glycyl-L-valine,  or glycyl-L- 
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FIo. 7. The  optical density of NBT  dye reduced during phagocytosis of pneumococci 
prepared with antibody and complement,  plotted as a function of the concentration (too- 
laxity) of glycyl-~-tyrosine  in the reaction volume. 
serine  (Table HI). NBT dye reduction after the ingestion of latex particles 
(0.81 p  diameter, Difco Laboratories, Detroit,  Mich.), which  do not require 
serum for ingestion, was not inhibited by 8 X  10  -a •  glycyl-L-tyrosine. These 
results suggested that the peptidase activity of C3 was essential for phagocyto- 
sis of pneumococci. 
When 0.19 mg of purified C3 was added to 0.08 ml C3-deficient  serum in the 
presence of 0.2 ml of the dialysate of human serum, a further  20 % enhance- 
ment of phagocytosis was achieved over that obtained with 0.19 mg C3 alone 
(Table IV). Heating the dialysate at 56°C for 30 min partially eliminated this 
effect, and heating at 56°C for 60 mill completely eliminated it. When dialysate 
as well as C1, C4, C2, and  C3 were used to prepare the pneumococci, phago- 
cytosis was further improved by approximately 13 % (Table IV). 
Enkancement by  PseudoglobuIin of Pkagocytosis of Pneumococci Prepared 1284  ENHANCEMENT  OF  BACTERIAL PHAGOCYTOSIS BY  SERUM 
with Antibody, C1,4,2,3,  and Dialysate.--It  was apparent  from  the  foregoing 
experiments that  the  peptidase  activity of  C3  is  required  for  the  enhance- 
ment of phagocytosis by complement. However, sensitization of the pneumo- 
cocci with  the first four components  in excess and  the dialyzable cofactor of 
TABLE III 
Activity  of Various Peptides in Inhibiting  the Phagocytosis of Pneumococci in the Presence 
of Serum 
Peptide added  Concentration of peptide  OD* 
(-) 
None 
Glycyl-L-leucine 
Glycyl-L-serine 
GlycybL-valine 
Glycyl-L-leucyl-L-tyrosine 
Glycyl-Ldeucyl-L-t  yrosine 
Glyeyl-L-tyrosine 
8×  10  -~ 
8×  10  -~ 
8 X  10  -~ 
4 X  10  -3 
9x  lo  ~ 
8×  10  -~ 
0.322 
0.313 
0.310 
0.319 
0.151 
0.209 
0.125 
* Optical density at 515 In# of NBT dye reduced during phagocytosis. 
TABLE IV 
Enhancement of Phagocytosis by a Dialyzable Serum Factor 
Serum and serum factors added  to sensitized  pneumococci  OD* 
Normal serum 
C3-deficient serum 
C3-deficient serum -1- dialysate 
C3-deficient serum +  C3 
C3-deficient serum -b C3 +  dialysate 
C3-deficient serum +  C3 -b dialysate heated 56°C, 30 rain 
C3-deficient serum +  C3 +  dialysate heated 56°C, 60 min 
C1,4,2,3 
C1,4,2,3 +  dialysate 
0.325 
0.072 
0.096 
0.290 
0.340 
0.327 
0.280 
0.217 
0.237 
* Optical density at 515 m# of NBT dye reduced during phagocytosis. 
C3  peptidase activity did not  promote phagocytosis as well  as  did  a  smaU 
volume of whole serum. 
Another serum component necessary for the optimal phagocytosis of pneu- 
mococci was obtained by separation of serum into pseudoglobulin and euglobu- 
lin fractions after overnight dialysis against  10 volumes of 0.02 ~t Na acetate 
buffer, pH 5.5. Fractions were dialyzed against veronal buffer before use, and 
0.05 ml of a  fraction was added to the assay mixture prior to the addition of 
purified C3. The pseudoglobulin fraction markedly enhanced the phagocytosis JOHNSTON, KLEMPERER, ALPER~ AND ROSEN  1285 
of pneumococci prepared with antibody, C1,4,2,3 and the dialysate of human 
serum (Table V). Pseudoglobulin obtained from serum of an individual with 
hereditary  angioneurotic  edema  (HANE  pseudoglobulin),  which  contained 
no hemolytically demonstrable C4 or C2 activity (31), was equally effective. 
Heating pseudoglobulin to 56°C for 30 min partially destroyed its ability to 
enhance phagocytosis (Table V). 
Pseudoglobulin was eluted from a DEAE cellulose cob,ran with 0.02 M Na phosphate 
buffer, pH 7.3 (conductance  at 25°C of 2875 # mho/cm). The DEAE eluate was concentrated 
10-fold by evaporation through dialysis tubing and separated by electrophoresis  on Pevikon 
(32) with barbital buffer, pH 8.6,/~ 0.1. Fractions were eluted at 1 cm intervals from the 
Pevikon and dialyzed against veronal buffer; 0.1 ml of a fraction was added to a reaction 
tube before the addition of C3. 
TABLE V 
Enhancement of Phagocytosis by a 5-6S, Beta Pseudoglobubin 
Complement components and co-factors added to  sensitized pneumococcl  0D* 
Pseudoglobulin 
C 1,4,2,3-dialysate 
C 1,4,2,3-dialysate-pseudoglobulin 
C  1,4,2,3-dialysate-I-IANE pseudoglobulin 
C1,4,2,3-dialysate-heated pseudoglobulin (56°C, 30 rain) 
C  1,4,2,3-dialysate-DEAE eluate 
C  1,4,2,3-dialysate-fl pseudoglobulin 
C  1,4,2,3-dialysate-5-6S globulin 
0.065 
0.232 
0.330 
O. 348 
0.287 
O. 338 
0.308 
0.334 
* Optical density at 515 m# of NBT dye reduced during phagocytosis. 
As  shown  in  Table V  phagocytosis-enhancing  activity was  found in  the 
region of the/3 globulins, 1-3 cm toward the anode from the origin. 
In order to estimate the molecular size of the/3 pseudoglobulin, serum was 
eluted  from  Sephadex  G-200  with  physiological saline.  The fraction eluted 
between  the 4S  and  7S  peaks  (5-6S)  contained significant phagocytosis-en- 
hancing activity (Table V). 
DISCUSSION 
Study of the role of sennn factors in the enhancement of bacterial phagocy- 
tosis has been facilitated by a spectrophotometric assay, utilizing the reduction 
of nitro blue tetrazolium  (NBT)  dye. NBT  dye enters  polymorphonuclear 
and monocytic phagocytes pari  passu  with ingested material and is reduced 
intraceUularly  (33),  apparently  as  the  result  of  release  of  reductases  from 
lysosomal granules which rupture after ingestion (34). Thus, the results of this 
assay are not influenced by particles merely adherent to the surface of phago- 1286  ENHANCEMF.NT  OF  BACTERIAL  PHAGOCYTOSIS  BY  SERUM 
cytes. The rate of dye reduction follows closely the rate of ingestion of pneumo- 
cocci as measured by the phagocytic index and by the uptake of mLpneumo- 
cocci by a monolayer of phagocytes (24). 
By  using  sera  deficient in  specific  complement components and  by  the 
sequential fixation of purified human C1, C4, C2, and C3, it has been shown 
that these four components, but not the later-acting components C5  through 
C9, are necessary for the optimal phagocytosis of pneumococci. This finding 
is in agreement with the work of Stiffel and coworkers (35) and Glynn and 
Medhurst (36),  who showed  that in vivo phagocytosis of Salmonella  typhi- 
raurium and Esckerichia  coli, respectively, was comparable in normal and C5- 
deficient mice. Similarly, Rother and Rother (37) and Biro and Garcia (38) 
showed that C6-deficient rabbits cleared the bloodstream of Salmonella  typki 
and aggregated gamma globulin as well as normal rabbits. 
Several previous  investigations have  suggested  that  serum factors  other 
than antibody and complement might enhance bacterial phagocytosis (39). 
The unavailability of purified  complement components at the time of these 
investigations prevented the precise separation of complement activity from 
that of other heat-labile factors. Although the exposure of sensitized pneumo- 
cocci  to  C1,4,2,3  increased phagocytosis,  an  excess  of  these  components 
did not promote phagocytosis as well as whole serum. 
Extending previous  work  (27,  28,  29),  Cooper and  Becket showed  that 
EAC1,4,2,3 hydrolyzed peptides containing aromatic amino acids (30), and 
Cooper showed that the hemolytic, immune adherence, and peptidase activi- 
ties of bound guinea pig C3 were enhanced by a dialyzable factor from guinea 
pig serum (22). A  dialyzate of human serum enhanced the phagocytosis of 
pneumococci prepared  with  7G  antibody and  purified human  components 
C1,4,2,3  in  the  experiments described  here.  Moreover,  phagocytosis  pro- 
moted by whole serum could be inhibited by the aromatic amino acid-contain- 
ing peptides, glycyl-tyrosine  and glycyl-leucyl-tyrosine.  It would appear, there- 
fore, that the peptidase activity of C3 fixed to an immune complex is essential 
for optimal phagocytosis. 
Cooper and Miiller-Eberhard  found  that  effective C3  peptidase activity 
(hydrolysis)  by  EAC1,4,2,3  required the binding of 300-400  molecules of 
C4,5  molecules of  oxidized  C2,  and  less  than  100  molecules  of C3  (40). 
They suggested that  the generation of peptidase activity may depend on a 
critical spatial  relationship  between C3  and  a  bound,  active  C4,2  site.  A 
requirement for ~0  as much C2 as C3  for peptidase activity might explain 
why C3-deficient  serum was much less effective in  supporting  phagocytosis 
than equal volumes of C2-deficient  serum. 
Although the dialyzable factor improved phagocytosis achieved by sensitiza- 
tion with purified complement components, the effect was still less than that 
of whole serum. However, when a 5-6S, beta pseudoglobulin  was added to the JOHNSTON~ KLEMPERER, ALPER~ AND ROSEN  1287 
assay system before the addition of C3, phagocytosis was comparable to that 
attained with fresh serum. This pseudoglobulin is similar in physicochemical 
characteristics to that protein which restored complement-mediated functions 
to the serum of a  young man with  recurrent  pyogenic infections and  rapid 
in vivo catabolism of C3 (41). Augmentation of phagocytosis by this cofactor 
might result from  stabilization  of C3  peptidase activity or inhibition  of en- 
zymatic inactivation  of  C3  by cell  bound  or  fluid  phase C4,~  (42)  or  by 
other C3-inactivating factors (43, 44). 
The complement requirement of C1,4,2,3  for bacterial phagocytosis is in 
accord with recent observations on the complement requirements for erythro- 
phagocytosis. Gigli and Nelson have demonstrated that the first four compo- 
nents  of  guinea  pig  complement  are  required  for  efficient  phagocyt0sis  of 
sensitized erythrocytes (45). Huber et al. (46) have shown that human mono- 
cytes possess distinct  receptor  sites for  the  adherence  and  phagocytosis of 
erythrocytes prepared with antibody and C 1,4,2,3 and erythrocyteS prepared 
with 7G antibody alone (EA). Prior treatment of the monocytes with trypsin 
inhibited  ingestion  of EAC1,4,2,3  but  not EA. The  role of C3 peptidase 
activity in erythrophagocytosis has not been determined.  : 
It is interesting to recall that Metchnlkoff suggested over 80 years ago that 
serum influenced phagocytosis by interaction with the phagocytic cell. Since 
C3 peptidase activity would seem essential for bacterial phagocytosis and  the 
attachment  of EAC1,4,2,3  to monocytes (46),  it  is  quite  possible that  a 
natural  substrate of this enzymatic activity resides  on the membrane of the 
phagocyte. 
S~kRY 
The role of serum factors in  the phagocytosis of pneumococci was studied 
employing  a  spectrophotometric  assay which  measures  reduced  nitro  blue 
tetrazolium  (NBT) dye. Dye reduction occurs within  the phagocyte shortly 
after bacterial ingestion as measured by the phagocytic index  technique and 
by the uptake of ~SI-pneumococci. Bacteria prepared with 7G antibody were 
not phagocytosed unless a  small volume of fresh normal  serum was added. 
Using fresh sera deficient in  single  complement  components, it was demon- 
strated that the first four components are necessary for optimal bacterial phago- 
cytosis. When highly purified complement components were added to the anti- 
body-coated pneumococci,  enhancement  of phagocytosis was achieved  only 
with the sequential addition of C1, C4, C2, and C3. 
Evidence has been presented that human C3 bound to an immune complex 
exhibits peptidase activity and that this activity is essential for phagocytosis. 
A heat-labile, dialyzable serum cofactor which enhances C3  peptidase activity 
enhanced the phagocytosis of pneumococci prepared with purified complement 
components. A second phagocytosis-promoting cofactor, which is: not a  coin- 1288  ENHANCEMENT  O!  ~  BACTERIAL  PHAGOCYTOSIS  BY  SERUM 
plement component, was found to be a heat-labile, 5-6S, beta pseudoglobulin. 
This protein may stabilize C3 peptidase activity or inhibit enzymatic inactiva- 
tion of C3. 
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